Trade Mark Journal No.2025/048 28 November 2025

UK00004296491 18 November 2025 (5)

LYRZO

Class 5: Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions.

AbbVie Inc.

Representative: Carpmaels & Ransford LLP